BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25621740)

  • 21. RalA but not RalB enhances polarized delivery of membrane proteins to the basolateral surface of epithelial cells.
    Shipitsin M; Feig LA
    Mol Cell Biol; 2004 Jul; 24(13):5746-56. PubMed ID: 15199131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calmodulin binds RalA and RalB and is required for the thrombin-induced activation of Ral in human platelets.
    Clough RR; Sidhu RS; Bhullar RP
    J Biol Chem; 2002 Aug; 277(32):28972-80. PubMed ID: 12034722
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ral GTPases in tumorigenesis: emerging from the shadows.
    Kashatus DF
    Exp Cell Res; 2013 Sep; 319(15):2337-42. PubMed ID: 23830877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of RalB-Sec5-TBK1 function in human oncogenesis.
    Chien Y; White MA
    Methods Enzymol; 2008; 438():321-9. PubMed ID: 18413258
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic deletion of RALA and RALB small GTPases reveals redundant functions in development and tumorigenesis.
    Peschard P; McCarthy A; Leblanc-Dominguez V; Yeo M; Guichard S; Stamp G; Marshall CJ
    Curr Biol; 2012 Nov; 22(21):2063-8. PubMed ID: 23063435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Different metastasis promotive potency of small G-proteins RalA and RalB in in vivo hamster tumor model.
    Rybko VA; Knizhnik AV; Komelkov AV; Aushev VN; Trukhanova LS; Tchevkina EM
    Cancer Cell Int; 2011 Jun; 11(1):22. PubMed ID: 21714887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector.
    Oxford G; Smith SC; Hampton G; Theodorescu D
    Oncogene; 2007 Nov; 26(50):7143-52. PubMed ID: 17496927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Geranylgeranyltransferase I inhibitors target RalB to inhibit anchorage-dependent growth and induce apoptosis and RalA to inhibit anchorage-independent growth.
    Falsetti SC; Wang DA; Peng H; Carrico D; Cox AD; Der CJ; Hamilton AD; Sebti SM
    Mol Cell Biol; 2007 Nov; 27(22):8003-14. PubMed ID: 17875936
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ral GTPase Activation by Downregulation of RalGAP Enhances Oral Squamous Cell Carcinoma Progression.
    Gao P; Liu S; Yoshida R; Shi CY; Yoshimachi S; Sakata N; Goto K; Kimura T; Shirakawa R; Nakayama H; Sakata J; Kawashiri S; Kato K; Wang XY; Horiuchi H
    J Dent Res; 2019 Aug; 98(9):1011-1019. PubMed ID: 31329042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mass spectroscopic phosphoprotein mapping of Ral binding protein 1 (RalBP1/Rip1/RLIP76).
    Herlevsen MC; Theodorescu D
    Biochem Biophys Res Commun; 2007 Oct; 362(1):56-62. PubMed ID: 17706599
    [TBL] [Abstract][Full Text] [Related]  

  • 31. RalB directly triggers invasion downstream Ras by mobilizing the Wave complex.
    Zago G; Veith I; Singh MK; Fuhrmann L; De Beco S; Remorino A; Takaoka S; Palmeri M; Berger F; Brandon N; El Marjou A; Vincent-Salomon A; Camonis J; Coppey M; Parrini MC
    Elife; 2018 Oct; 7():. PubMed ID: 30320548
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis.
    Jullien-Flores V; Mahé Y; Mirey G; Leprince C; Meunier-Bisceuil B; Sorkin A; Camonis JH
    J Cell Sci; 2000 Aug; 113 ( Pt 16)():2837-44. PubMed ID: 10910768
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ral small GTPase signaling and oncogenesis: More than just 15minutes of fame.
    Gentry LR; Martin TD; Reiner DJ; Der CJ
    Biochim Biophys Acta; 2014 Dec; 1843(12):2976-2988. PubMed ID: 25219551
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tissue-specific expression of GTPas RalA and RalB during embryogenesis and regulation by epithelial-mesenchymal interaction.
    Zhao Z; Rivkees SA
    Mech Dev; 2000 Oct; 97(1-2):201-4. PubMed ID: 11025226
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NMR resonance assignments for the active and inactive conformations of the small G protein RalA.
    Shafiq A; Campbell LJ; Owen D; Mott HR
    Biomol NMR Assign; 2020 Apr; 14(1):87-91. PubMed ID: 31916136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exo84 and Sec5 are competitive regulatory Sec6/8 effectors to the RalA GTPase.
    Jin R; Junutula JR; Matern HT; Ervin KE; Scheller RH; Brunger AT
    EMBO J; 2005 Jun; 24(12):2064-74. PubMed ID: 15920473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RalB mobilizes the exocyst to drive cell migration.
    Rossé C; Hatzoglou A; Parrini MC; White MA; Chavrier P; Camonis J
    Mol Cell Biol; 2006 Jan; 26(2):727-34. PubMed ID: 16382162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The RalGEF/Ral pathway: evaluating an intervention opportunity for Ras cancers.
    Cooper JM; Bodemann BO; White MA
    Enzymes; 2013; 34 Pt. B():137-56. PubMed ID: 25034103
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ral isoforms are implicated in Fc gamma R-mediated phagocytosis: activation of phospholipase D by RalA.
    Corrotte M; Nyguyen AP; Harlay ML; Vitale N; Bader MF; Grant NJ
    J Immunol; 2010 Sep; 185(5):2942-50. PubMed ID: 20679536
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The RAL signaling network: Cancer and beyond.
    Apken LH; Oeckinghaus A
    Int Rev Cell Mol Biol; 2021; 361():21-105. PubMed ID: 34074494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.